Koers Medeon Biodesign, Inc.
Aandelen
6499
TW0006499007
Geavanceerde medische apparatuur & technologie
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
42,65 TWD | +0,35% | +0,83% | -8,57% |
Omzet 2022 | 298 mln. 9,16 mln. 8,55 mln. | Omzet 2023 | 196 mln. 6,02 mln. 5,63 mln. | Marktkapitalisatie | 4,29 mld. 132 mln. 123 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -434 mln. -13,32 mln. -12,44 mln. | Nettowinst (verlies) 2023 | -1,2 mld. -36,99 mln. -34,55 mln. | EV/omzet 2022 | 12,5 x |
Nettoliquiditeiten 2022 | 1,35 mld. 41,39 mln. 38,66 mln. | Nettoliquiditeiten 2023 | 1,96 mld. 60,02 mln. 56,06 mln. | EV/omzet 2023 | 11,9 x |
K/w-verhouding 2022 |
-11,7
x | K/w-verhouding 2023 |
-3,56
x | Werknemers | 39 |
Dividendrendement 2022 |
0,86% | Dividendrendement 2023 |
-
| Vrij verhandelbaar | 47,57% |
1 dag | +0,35% | ||
1 week | +0,83% | ||
Lopende maand | -1,50% | ||
1 maand | -1,16% | ||
3 maanden | -7,28% | ||
6 maanden | -11,51% | ||
Lopend jaar | -8,57% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yu Te Chang
CEO | Chief Executive Officer | - | 22-12-12 |
Ching Yi Chen
DFI | Director of Finance/CFO | - | - |
Greta Chang
PRN | Corporate Officer/Principal | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yu Te Chang
CEO | Chief Executive Officer | - | 22-12-12 |
Chih Lung Shen
BRD | Director/Board Member | 59 | 20-04-15 |
Hong Jen Chang
BRD | Director/Board Member | 68 | 14-01-14 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 42,65 | +0,35% | 26 773 |
25-04-24 | 42,5 | +0,24% | 10 448 |
24-04-24 | 42,4 | +0,36% | 67 671 |
23-04-24 | 42,25 | +0,12% | 28 303 |
22-04-24 | 42,2 | -0,24% | 31 099 |
slotkoers Taipei Exchange, 26 april 2024
Meer koersenKwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-8,57% | 120 mln. | |
+8,07% | 219 mld. | |
+6,59% | 183 mld. | |
+11,26% | 133 mld. | |
+26,57% | 108 mld. | |
+0,65% | 63,06 mld. | |
+13,35% | 52,02 mld. | |
-0,62% | 48,2 mld. | |
-0,93% | 40,37 mld. | |
+11,54% | 39,35 mld. |